IMRT Technique

RADIATION2 trials

Sponsors

McGill University Health Centre/Research Institute of the McGill University Health Centre, Sergio Faria

Conditions

Glioblastoma MutliformeHigh Risk Prostate Cancer

Unknown Phase

Phase II Trial of Neo-adjuvant Temozolomide Prior to Combined Temozolomide and Concurrent Accelerated Hypofractionated External Beam Radiotherapy Followed by Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme

CompletedNCT01702610

McGill University Health Centre/Research Institute of the McGill University Health CentreGlioblastoma Mutliforme

Start: 2008-12-31End: 2014-12-31Updated: 2016-09-28

Hypofractionated Intensity Modulated Radiation Therapy Plus Hormonal Therapy in Patients With High Risk Prostate Cancer

CompletedNCT02107287

Sergio FariaHigh Risk Prostate Cancer

Start: 2011-08-31End: 2016-06-30Updated: 2016-09-27

Related Papers

Acute and late toxicity in high-risk prostate cancer patients treated with androgen suppression and hypofractionated pelvic radiotherapy.

Journal of Clinical Oncology2017-02-20